Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Hairless protein can block vitamin D activation in skin cells.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Plet-1 protein helps hair follicle cells move and stick to tissues.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Osmanthus fragrans var. aurantiacus Makino may help treat inflammation due to its antioxidative and anti-inflammatory properties.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

PCOS causes inflammation regardless of body weight.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Future acne treatments should aggressively target inflammation to prevent scarring.

Certain gene variations are linked to alopecia areata.

PRP may help reduce brain inflammation and protect brain cells.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Dermal factors are crucial in regulating melanin production in skin.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

ILC1 cells contribute to hair loss in alopecia areata.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.